Listed

GENELUX Corp: Form 10-Q for the period ended Mar 31, 2023

Filed with the SEC on May 15, 2023 and accepted by EDGAR at May 15, 2023, 06:11 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2023-01-01 to 2023-03-31$170.0kus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Research and development3 months2023-01-01 to 2023-03-31$2.8mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2023-01-01 to 2023-03-31−$6.5mus-gaap:OperatingIncomeLoss
Net income3 months2023-01-01 to 2023-03-31−$10.4mus-gaap:NetIncomeLoss
Basic EPS3 months2023-01-01 to 2023-03-31−$0.53us-gaap:EarningsPerShareBasic
Operating cash flow3 months2023-01-01 to 2023-03-31−$4.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2023-01-01 to 2023-03-31$109.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2023-03-31$10.3mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2023-03-31$12.1mus-gaap:AssetsCurrent
Total assetsAt period end2023-03-31$14.6mus-gaap:Assets
Current liabilitiesAt period end2023-03-31$10.5mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2023-03-31$11.9mus-gaap:Liabilities
Short-term borrowingsAt period end2023-03-31$900.0kus-gaap:ShortTermBorrowings
Shareholders' equityAt period end2023-03-31$2.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001493152-23-016832. Last ingested by Listed: Oct 24, 2026, 15:10 ET. Listed shows no prices and gives no investment advice.